India develops cost-effective handheld X-ray for TB screening

Developed through a partnership between IIT Kanpur and the Indian Council of Medical Research (ICMR), this new device aims to boost early TB detection by providing a more affordable alternative to imported equipment.

The device costs less than half the price of international models and is designed to improve access to TB screenings, particularly for underserved communities, by offering portable and convenient testing options near patients' homes.

ICMR Director General Rajiv Bahl highlighted this innovation during the 19th International Conference of Drug Regulatory Authorities (ICDRA) INDIA-2024.

He emphasized that this new technology could have a significant impact on public health in India by enabling more widespread and timely diagnosis and treatment of TB.

Bahl also announced the creation of three Mpox testing kits, currently being produced by three different companies, as part of the country’s ongoing healthcare advancements.

The fight against sickle cell disease was another focus. India, with over a million affected individuals, has the world's second-largest population of sickle cell patients.

The ICMR Director General revealed that 18 new, low-cost tests for detecting sickle cell anemia have been developed, bringing down the cost from Rs 400 to just Rs 30 per test, making screening far more affordable.

This development aligns with the National Sickle Cell Anaemia Elimination Mission, launched by Prime Minister Narendra Modi last year, which aims to eradicate the disease as a public health issue by 2047.

In other health news, India is in the third phase of clinical trials for a dengue vaccine, according to reports.

Bahl expressed hope for positive results within a year.

If proven safe and effective, the vaccine could become a critical asset in the country’s efforts to control dengue.